Reference Richardson, Little and Little6 Isoniazid is a narrow therapeutic window medication used for tuberculosis treatment. With an estimated LD50 (lethal dose for 50% of the population) of 50 mg/kg ...

WHO has also endorsed low-complexity molecular tests for detecting isoniazid resistance that are technologically suitable for peripheral-level use in low-resource settings. 5 These ...

Our objective was to evaluate the efficacy of isoniazid in prevention of tuberculosis morbidity and mortality in children aged 15 years or younger by performing a meta-analysis of randomized ...

In an exciting new development, researchers have created a unique way to deliver Tuberculosis (TB) medicines directly to the ...

Maharashtra launches a groundbreaking 28-day TB treatment for HIV patients aiming to reduce mortality and improve healthcare ...

In a pioneering discovery, scientists at the Institute of Nano Science and Technology (INST), Mohali, have developed a ...

Scientists from the Institute of Nano Science and Technology in Mohali have developed a novel way to deliver medicines for ...

India's focus on tuberculosis research, including antimicrobial resistance, Mtb survival mechanisms, and potential new ...

They can hold TB drugs like isoniazid (INH) and rifampicin (RIF). The drug delivery technology used was nose-to-brain (N2B) ...

In my pharmacy practice we recently fell short and were unable to fill a prescription for isoniazid due to a national shortage of the drug. It gave me pause to think that even old reliable drugs ...